74 related articles for article (PubMed ID: 10873604)
1. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
2. A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.
Li QX; Robbins JM; Welch PJ; Wong-Staal F; Barber JR
Nucleic Acids Res; 2000 Jul; 28(13):2605-12. PubMed ID: 10871412
[TBL] [Abstract][Full Text] [Related]
3. Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts.
Dawson PA; Marini JC
Nucleic Acids Res; 2000 Oct; 28(20):4013-20. PubMed ID: 11024182
[TBL] [Abstract][Full Text] [Related]
4. Construction of an effective m1 GS ribozyme targeting HCMV UL97 mRNA segment in vitro.
Zhang WJ; Li HJ; Li YQ; He HK; Tang DS; Zhang X; Zhou TH
Yi Chuan Xue Bao; 2005 Nov; 32(11):1205-12. PubMed ID: 16318287
[TBL] [Abstract][Full Text] [Related]
5. Computational selection and experimental validation of allosteric ribozymes that sense a specific sequence of human telomerase reverse transcriptase mRNAs as universal anticancer therapy agents.
Penchovsky R; Kostova GT
Nucleic Acid Ther; 2013 Dec; 23(6):408-17. PubMed ID: 24206267
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells.
Elayadi AN; Demieville A; Wancewicz EV; Monia BP; Corey DR
Nucleic Acids Res; 2001 Apr; 29(8):1683-9. PubMed ID: 11292840
[TBL] [Abstract][Full Text] [Related]
7. Hammerhead ribozyme design and application.
Amarzguioui M; Prydz H
Cell Mol Life Sci; 1998 Nov; 54(11):1175-202. PubMed ID: 9849614
[TBL] [Abstract][Full Text] [Related]
8. A Discovery with Potential to Revitalize Hammerhead Ribozyme Therapeutics for Treatment of Inherited Retinal Degenerations.
Trujillo AJ; Myers JM; Fayazi ZS; Butler MC; Sullivan JM
Adv Exp Med Biol; 2019; 1185():119-124. PubMed ID: 31884599
[TBL] [Abstract][Full Text] [Related]
9. Improving the efficiency of antisense and EGS methods.
Salavati R; Altman S
Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):63-5. PubMed ID: 9512097
[TBL] [Abstract][Full Text] [Related]
10. Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations.
Amir M; Khan P; Queen A; Dohare R; Alajmi MF; Hussain A; Islam A; Ahmad F; Hassan I
Cells; 2020 Feb; 9(2):. PubMed ID: 32033110
[TBL] [Abstract][Full Text] [Related]
11. Polyunsaturated fatty acids ameliorate aging via redox-telomere-antioncogene axis.
Chen J; Wei Y; Chen X; Jiao J; Zhang Y
Oncotarget; 2017 Jan; 8(5):7301-7314. PubMed ID: 28038469
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic targeting of replicative immortality.
Yaswen P; MacKenzie KL; Keith WN; Hentosh P; Rodier F; Zhu J; Firestone GL; Matheu A; Carnero A; Bilsland A; Sundin T; Honoki K; Fujii H; Georgakilas AG; Amedei A; Amin A; Helferich B; Boosani CS; Guha G; Ciriolo MR; Chen S; Mohammed SI; Azmi AS; Bhakta D; Halicka D; Niccolai E; Aquilano K; Ashraf SS; Nowsheen S; Yang X
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S104-S128. PubMed ID: 25869441
[TBL] [Abstract][Full Text] [Related]
13. Targeting human telomerase for cancer therapeutics.
Guittat L; Alberti P; Gomez D; De Cian A; Pennarun G; Lemarteleur T; Belmokhtar C; Paterski R; Morjani H; Trentesaux C; Mandine E; Boussin F; Mailliet P; Lacroix L; Riou JF; Mergny JL
Cytotechnology; 2004 Jun; 45(1-2):75-90. PubMed ID: 19003245
[TBL] [Abstract][Full Text] [Related]
14. Telomerase inhibition in cancer therapeutics: molecular-based approaches.
Cunningham AP; Love WK; Zhang RW; Andrews LG; Tollefsbol TO
Curr Med Chem; 2006; 13(24):2875-88. PubMed ID: 17073634
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligonucleotide targeting at the initiator of hTERT arrests growth of hepatoma cells.
Liu SX; Sun WS; Cao YL; Ma CH; Han LH; Zhang LN; Wang ZG; Zhu FL
World J Gastroenterol; 2004 Feb; 10(3):366-70. PubMed ID: 14760759
[TBL] [Abstract][Full Text] [Related]
16. Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells.
Sun L; Wang X
World J Gastroenterol; 2003 Sep; 9(9):1930-4. PubMed ID: 12970878
[TBL] [Abstract][Full Text] [Related]
17. An introduction to telomeres and telomerase.
Bibby MC
Mol Biotechnol; 2003 Jul; 24(3):295-301. PubMed ID: 12777695
[TBL] [Abstract][Full Text] [Related]
18. Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.
Hao ZM; Luo JY; Cheng J; Wang QY; Yang GX
World J Gastroenterol; 2003 Jan; 9(1):104-7. PubMed ID: 12508361
[TBL] [Abstract][Full Text] [Related]
19. Natural and pharmacological regulation of telomerase.
Mergny JL; Riou JF; Mailliet P; Teulade-Fichou MP; Gilson E
Nucleic Acids Res; 2002 Feb; 30(4):839-65. PubMed ID: 11842096
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
